Gabriel Vargas

1.4k total citations
31 papers, 1.0k citations indexed

About

Gabriel Vargas is a scholar working on Psychiatry and Mental health, Molecular Biology and Physiology. According to data from OpenAlex, Gabriel Vargas has authored 31 papers receiving a total of 1.0k indexed citations (citations by other indexed papers that have themselves been cited), including 11 papers in Psychiatry and Mental health, 9 papers in Molecular Biology and 9 papers in Physiology. Recurrent topics in Gabriel Vargas's work include Migraine and Headache Studies (7 papers), Electrolyte and hormonal disorders (4 papers) and Sympathectomy and Hyperhidrosis Treatments (4 papers). Gabriel Vargas is often cited by papers focused on Migraine and Headache Studies (7 papers), Electrolyte and hormonal disorders (4 papers) and Sympathectomy and Hyperhidrosis Treatments (4 papers). Gabriel Vargas collaborates with scholars based in United States, Switzerland and Belgium. Gabriel Vargas's co-authors include Mark von Zastrow, Richard B. Mailman, Jonathan D. Urban, Stephen M. Rosenthal, Stephen E. Gitelman, Brian J. Feldman, Mina Matsuda‐Abedini, Raymond G. Fenwick, Robert H. Lustig and Eric A. Huang and has published in prestigious journals such as New England Journal of Medicine, Journal of Biological Chemistry and Journal of Clinical Investigation.

In The Last Decade

Gabriel Vargas

29 papers receiving 1.0k citations

Peers

Countries citing papers authored by Gabriel Vargas

Since Specialization

Citations

This map shows the geographic impact of Gabriel Vargas's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Gabriel Vargas with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Gabriel Vargas more than expected).

Fields of papers citing papers by Gabriel Vargas

Since Specialization

Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Gabriel Vargas. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Gabriel Vargas. The network helps show where Gabriel Vargas may publish in the future.

Co-authorship network of co-authors of Gabriel Vargas

This figure shows the co-authorship network connecting the top 25 collaborators of Gabriel Vargas. A scholar is included among the top collaborators of Gabriel Vargas based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Gabriel Vargas. Gabriel Vargas is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

Sort: Min cites: Since: Top N: Style:

20 of 20 papers shown

#	Work	Indexed citations
1	Single‐ and Multiple‐Dose Pharmacokinetics of Gefapixant (MK‐7264), a P2X3 Receptor Antagonist, in Healthy Adults 2024 ·The Journal of Clinical Pharmacology ·Jesse C. Nussbaum, Azher Hussain, P. Butera, Anthony Ford, Michael M. Kitt, Edward A. O’Neill, Steven A. Smith, Gabriel Vargas, Terry O’Reilly, Chris Wynne, S. Aubrey Stoch, Marian Iwamoto	4
2	Effects on cerebral blood flow after single doses of the β₂ agonist, clenbuterol, in healthy volunteers and patients with mild cognitive impairment or Parkinson's disease 2024 ·British Journal of Clinical Pharmacology ·(unknown), Jan de Hoon, Koen Van Laere, Edgar Bautista, Gaia Rizzo, Courtney Bishop, Eugenii A. Rabiner, Renée S. Martin, Anthony Ford, Gabriel Vargas	0
3	Locus Coeruleus and Noradrenergic Pharmacology in Neurodegenerative Disease 2023 ·Handbook of experimental pharmacology ·Rachel A. Matt, Renée S. Martin, Andrew K. Evans, Joel R. Gever, Gabriel Vargas, Mehrdad Shamloo, Anthony Ford	4
4	Detection of Clenbuterol-Induced Changes in Heart Rate Using At-Home Recorded Smartwatch Data: Randomized Controlled Trial 2021 ·JMIR Formative Research ·(unknown), (unknown), (unknown), Pim Gal, Gabriel Vargas, Geert Jan Groeneveld, Robert J. Doll	5
5	Relationship between infarct size and serum uric acid levels during the acute phase of stroke 2019 ·PLoS ONE ·Rodrigo Fernández-Gajardo, José Manuel Matamala, Rodrigo Gutiérrez, (unknown), (unknown), Camilo G. Sotomayor, (unknown), (unknown), Gabriel Vargas, Rodrigo Guerrero, Pablo Reyes, Gabriel Cavada, Walter Feuerhake, Ramón Rodrigo	10
6	Experiencia en el tratamiento endovascular del accidente cerebrovascular isquémico agudo en un centro chileno 2018 ·Revista médica de Chile ·(unknown), (unknown), (unknown), (unknown), Rodrigo Rivera, (unknown), (unknown), (unknown), Gabriel Vargas, Paula Alexandra Silva, Rodrigo Guerrero, Walter Feuerhake	3
7	Digital technologies as biomarkers, clinical outcomes assessment, and recruitment tools in Alzheimer's disease clinical trials 2018 ·Alzheimer s & Dementia Translational Research & Clinical Interventions ·Michael Gold, Joan Amatniek, María C. Carrillo, Jesse M. Cedarbaum, James A. Hendrix, Bradley B. Miller, Julie M. Robillard, John Jeremy Rice, Holly Soares, Maria Tome, Ioannis Tarnanas, Gabriel Vargas, Lisa J. Bain, Sara J. Czaja	99
8	Phase 1, Randomized, Parallel-Group, Double-Blind, Placebo-Controlled Trial to Evaluate the Effects of Erenumab (AMG 334) and Concomitant Sumatriptan on Blood Pressure in Healthy Subjects (P2.161) 2017 ·Neurology ·Jan de Hoon, Anne Van Hecken, Corinne Vandermeulen, (unknown), Yumi Kubo, Ed Lee, (unknown), Gabriel Vargas, (unknown)	2
9	Pharmacokinetic-Pharmacodynamic Relationship of Erenumab (AMG 334) and Capsaicin-Induced Dermal Blood Flow in Healthy and Migraine Subjects 2017 ·Pharmaceutical Research ·Thuy Vu, Peiming Ma, (unknown), Jan de Hoon, Anne Van Hecken, Lucy Yan, (unknown), Lisa Hamilton, Gabriel Vargas	72
10	Pharmacokinetic/pharmacodynamic modeling of monoclonal antibody AMG 334 to characterize concentration relationship with capsaicin-induced increase in dermal blood flow in healthy subjects and migraine patients 2015 ·Cephalalgia ·(unknown), (unknown), Jialin Chen, Jan de Hoon, Anne Van Hecken, (unknown), Lisa Hamilton, Gabriel Vargas	1
11	Characterizing the Relationship Between AMG 334 Concentration and Capsaicin-Induced Increase in Dermal Blood Flow in Healthy Subjects and Migraine Patients Using Pharmacokinetic-Pharmacodynamic Modeling 2015 ·Headache The Journal of Head and Face Pain ·(unknown), (unknown), Jialin Chen, Jan de Hoon, Anne Van Hecken, (unknown), Lisa Hamilton, Gabriel Vargas	2
12	Biomarkers for Antipsychotic Therapies 2012 ·Handbook of experimental pharmacology ·Emilio Merlo Pich, Gabriel Vargas, Enrico Domenici	9
13	Contingent negative variation as a dopaminergic biomarker: evidence from dose-related effects of methylphenidate 2011 ·Psychopharmacology ·A.M.W. Linssen, Eric Vuurman, Anke Sambeth, Stephane Navé, Will Spooren, Gabriel Vargas, Luca Santarelli, Wim J. Riedel	58
14	Arguments Against Precompetitive Collaboration 2010 ·Clinical Pharmacology & Therapeutics ·Gabriel Vargas, Bruno Boutouyrie, Susanne Ostrowitzki, Lory Santarelli	9
15	Functional Characterization of Vasopressin Type 2 Receptor Substitutions (R137H/C/L) Leading to Nephrogenic Diabetes Insipidus and Nephrogenic Syndrome of Inappropriate Antidiuresis: Implications for Treatments 2010 ·Molecular Pharmacology ·Moulay Driss Rochdi, Gabriel Vargas, Éric Le Carpentier, (unknown), (unknown), Abraham Kovoor, Stephen E. Gitelman, Stephen M. Rosenthal, Mark von Zastrow, Michel Bouvier	53
16	Engineered Protein Connectivity to Actin Mimics PDZ-dependent Recycling of G Protein-coupled Receptors but Not Its Regulation by Hrs 2008 ·Journal of Biological Chemistry ·Benjamin Lauffer, (unknown), Cristina Melero, Tanja Kortemme, Mark von Zastrow, Gabriel Vargas	15
17	Gain-of-Function Mutations in the V2 Vasopressin Receptor 2007 ·Hormone Research in Paediatrics ·Stephen M. Rosenthal, Stephen E. Gitelman, Gabriel Vargas, Brian J. Feldman	3
18	Nephrogenic Syndrome of Inappropriate Antidiuresis 2005 ·New England Journal of Medicine ·Brian J. Feldman, Stephen M. Rosenthal, Gabriel Vargas, Raymond G. Fenwick, Eric A. Huang, Mina Matsuda‐Abedini, Robert H. Lustig, Robert S. Mathias, Anthony A. Portale, Walter L. Miller, Stephen E. Gitelman	242
19	Identification of a Novel Endocytic Recycling Signal in the D1 Dopamine Receptor 2004 ·Journal of Biological Chemistry ·Gabriel Vargas, Mark von Zastrow	61
20	Reduced epidermal growth factor receptor expression in hypohidrotic ectodermal dysplasia and Tabby mice. 1996 ·Journal of Clinical Investigation ·Gabriel Vargas, Emmanuelle Fantino, C George-Nascimento, J. Jay Gargus, Harry T. Haigler	35

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact